Cargando…

Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study

The outcomes after septal myectomy in young children and infants with hypertrophic obstructive cardiomyopathy (HOCM) are not clear. The study sought to report the outcomes after septal myectomy in young children and infants and identify the mechanisms of residual or recurrent obstruction after surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Shuo, Du, Chuhao, Song, Jiangping, Dong, Jie, Meng, Hong, Xu, Haitao, Sun, Yangxue, Zou, Mengxuan, Li, Shoujun, Yan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389362/
https://www.ncbi.nlm.nih.gov/pubmed/37165977
http://dx.doi.org/10.1097/JS9.0000000000000426
_version_ 1785082282398187520
author Dong, Shuo
Du, Chuhao
Song, Jiangping
Dong, Jie
Meng, Hong
Xu, Haitao
Sun, Yangxue
Zou, Mengxuan
Li, Shoujun
Yan, Jun
author_facet Dong, Shuo
Du, Chuhao
Song, Jiangping
Dong, Jie
Meng, Hong
Xu, Haitao
Sun, Yangxue
Zou, Mengxuan
Li, Shoujun
Yan, Jun
author_sort Dong, Shuo
collection PubMed
description The outcomes after septal myectomy in young children and infants with hypertrophic obstructive cardiomyopathy (HOCM) are not clear. The study sought to report the outcomes after septal myectomy in young children and infants and identify the mechanisms of residual or recurrent obstruction after surgery. METHODS: The authors performed an observational cohort study of children and infants under the age of 14 who underwent septal myectomy for HCOM from January 2013 to December 2020. Mean follow-up among 94.3% (n=50) of hospital survivors was 42.09±24.38 months. RESULTS: In total, 56 children and infants [mean (SD) age, 5.38 (3.78) years; 29 (58.1%) were male] underwent septal myectomy for HOCM. Cumulative survival was 100, 96.6, 93.0, and 81.4% at 1, 3, 5, and 7 years, respectively, among hospital survivors. The incidence of residual and recurrent obstruction was 14.3% (8/56) and 13.0% (6/46), respectively. The mechanisms of residual obstruction were identified as subaortic obstruction caused by inadequacy of previous septal excision in two patients, midventricular obstruction caused by inadequacy of septal excision in five patients, and untreated abnormal papillary muscles in one patient. Recurrent obstruction was caused by isolated midventricular obstruction (n=4) and newly emerged systolic anterior motion (SAM)-related subaortic obstruction combining abnormal mitral valve apparatus (n=2). Residual or recurrent obstruction was associated with age less than 2 years at surgery (OR=6.157, 95% CI: 1.487–25.487, P=0.012) and biventricular outflow obstruction (OR=6.139, 95% CI: 1.292–29.172, P=0.022). Recurrent obstruction was associated with age less than 2 years at surgery (OR=6.976, 95% CI: 1.233–39.466, P=0.028). CONCLUSIONS: Septal myectomy is still effective and safe in young children and infants. The rate of residual or recurrent obstruction with diverse causes is relatively high, which is more likely to occur in children aged less than 2 years at surgery and those with biventricular obstruction.
format Online
Article
Text
id pubmed-10389362
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103893622023-08-01 Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study Dong, Shuo Du, Chuhao Song, Jiangping Dong, Jie Meng, Hong Xu, Haitao Sun, Yangxue Zou, Mengxuan Li, Shoujun Yan, Jun Int J Surg Original Research The outcomes after septal myectomy in young children and infants with hypertrophic obstructive cardiomyopathy (HOCM) are not clear. The study sought to report the outcomes after septal myectomy in young children and infants and identify the mechanisms of residual or recurrent obstruction after surgery. METHODS: The authors performed an observational cohort study of children and infants under the age of 14 who underwent septal myectomy for HCOM from January 2013 to December 2020. Mean follow-up among 94.3% (n=50) of hospital survivors was 42.09±24.38 months. RESULTS: In total, 56 children and infants [mean (SD) age, 5.38 (3.78) years; 29 (58.1%) were male] underwent septal myectomy for HOCM. Cumulative survival was 100, 96.6, 93.0, and 81.4% at 1, 3, 5, and 7 years, respectively, among hospital survivors. The incidence of residual and recurrent obstruction was 14.3% (8/56) and 13.0% (6/46), respectively. The mechanisms of residual obstruction were identified as subaortic obstruction caused by inadequacy of previous septal excision in two patients, midventricular obstruction caused by inadequacy of septal excision in five patients, and untreated abnormal papillary muscles in one patient. Recurrent obstruction was caused by isolated midventricular obstruction (n=4) and newly emerged systolic anterior motion (SAM)-related subaortic obstruction combining abnormal mitral valve apparatus (n=2). Residual or recurrent obstruction was associated with age less than 2 years at surgery (OR=6.157, 95% CI: 1.487–25.487, P=0.012) and biventricular outflow obstruction (OR=6.139, 95% CI: 1.292–29.172, P=0.022). Recurrent obstruction was associated with age less than 2 years at surgery (OR=6.976, 95% CI: 1.233–39.466, P=0.028). CONCLUSIONS: Septal myectomy is still effective and safe in young children and infants. The rate of residual or recurrent obstruction with diverse causes is relatively high, which is more likely to occur in children aged less than 2 years at surgery and those with biventricular obstruction. Lippincott Williams & Wilkins 2023-05-11 /pmc/articles/PMC10389362/ /pubmed/37165977 http://dx.doi.org/10.1097/JS9.0000000000000426 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Research
Dong, Shuo
Du, Chuhao
Song, Jiangping
Dong, Jie
Meng, Hong
Xu, Haitao
Sun, Yangxue
Zou, Mengxuan
Li, Shoujun
Yan, Jun
Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
title Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
title_full Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
title_fullStr Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
title_full_unstemmed Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
title_short Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
title_sort residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389362/
https://www.ncbi.nlm.nih.gov/pubmed/37165977
http://dx.doi.org/10.1097/JS9.0000000000000426
work_keys_str_mv AT dongshuo residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT duchuhao residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT songjiangping residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT dongjie residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT menghong residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT xuhaitao residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT sunyangxue residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT zoumengxuan residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT lishoujun residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy
AT yanjun residualorrecurrentobstructionafterseptalmyectomyinyoungchildrenandinfantswithhypertrophiccardiomyopathycohortstudy